(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Sodium Salt, ~70%

CAS: 1062122-63-7 220127-31-1

Ref. TR-H825290

Informação sobre produto

• Nome: (19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Sodium Salt, ~70%
• Sinónimos: (2S)-1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E/Z,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-2-piperidinecarboxylic Acid Sodium Salt, seco Everolimus Sodium Salt
• CAS: 1062122-63-7 220127-31-1

Descrição

Stability Light Sensitive
Applications Metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).
References Vidal, C. et al.: J. Am. Soc. Mass Spec., 9, 1267 (1998); Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001);

• Marca: TRC

Propriedades químicas

• Peso molecular: 980.21
• Fórmula: C₅₃H₈₂NNaO₁₄
• Pureza: ~70%
• Cor/forma: Neat
• InChI: InChI=1S/C53H83NO14.Na/c1-33(16-12-11-13-17-35(3)45(64-8)32-41-22-20-39(7)53(63,68-41)50(59)51(60)54-25-15-14-18-42(54)52(61)62)28-37(5)47(57)49(66-10)48(58)38(6)30-36(4)43(56)23-19-34(2)29-40-21-24-44(67-27-26-55)46(31-40)65-9;/h11-13,16-17,19,23,30,33-34,36-37,39-42,44-46,48-49,55,58,63H,14-15,18,20-22,24-29,31-32H2,1-10H3,(H,61,62);/q;+1/p-1/b13-11+,16-12+,23-19+,35-17+,38-30+;/t33-,34+,36-,37-,39-,40+,41+,42+,44-,45+,46-,48-,49+,53-;/m1./s1
• Chave InChI: InChIKey=JZTVNCOLMGNTNU-MLOFORPHSA-M
• SMILES: CO[C@@H](C[C@@H]1CC[C@@H](C)[C@](O)(C(=O)C(=O)N2CCCC[C@H]2C(=O)O[Na])O1)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]1CC[C@@H](OCCO)[C@H](OC)C1